Friends: This has been a pivotal year for Ovarian Cancer Research Alliance (OCRA), defined by powerful forward momentum—from launching the Global Ovarian Cancer Research Consortium to preparing the Community Accelerated Research Exchange for its debut, expanding essential support and education programs, and establishing our new Center for Public Policy. These developments, along with the progress highlighted below, signal a turning … Continued
Friends, As we approach the end of the year, one thing stands out above all else: this is a moment of unprecedented opportunity to accelerate progress against ovarian and all gynecologic cancers. And thanks to you, OCRA is rising to meet that moment — driving innovation, expanding support, and providing the community that so many … Continued
KVIA-TV ABC-7 News El Paso recently featured OCRA-funded researcher Daniel Heller, PhD, and his team at Memorial Sloan Kettering Cancer Center, whose innovative work is bringing new hope for detecting ovarian cancer at its earliest stages through a simple blood test. Dr. Heller’s research lab is developing a liquid biopsy that uses nanosensors and artificial intelligence (AI) to measure multiple proteins … Continued
Friends: September was nothing short of extraordinary. Our community came together with passion and purpose for Ovarian & Gynecologic Cancer Awareness Month, and together we not only met our fundraising goal but exceeded it — raising more than $370,000 to power research, strengthen patient support, and amplify advocacy for those who need it most. Throughout the month, … Continued
September is Ovarian and Gynecologic Cancer Awareness Month — a time for our community to unite, raise awareness, and push forward in the search for better treatments and cures. As the world’s largest organization dedicated to fighting ovarian and all gynecologic cancers on all fronts, Ovarian Cancer Research Alliance (OCRA) is setting out to raise $300,000 this … Continued
OCRA Rivkin Family SummeRun Raises Over $320,000 for Research More than 900 participants gathered at Seattle’s Seward Park for the Ovarian Cancer Research Alliance (OCRA) Rivkin Family SummeRun, raising more than $320,000 to advance innovative ovarian cancer research. Now in its 32nd year, the beloved 5K run/walk brought together survivors, families, friends, and supporters—all united in … Continued
OCRA Featured in Fortune Article on Surgery That Reduces Ovarian Cancer Risk Ovarian Cancer Research Alliance’s (OCRA) leadership in raising awareness about opportunistic salpingectomy—a simple procedure that can significantly reduce the risk of ovarian cancer—is at the center of a new Fortune article. The story features a personal perspective from journalist and breast cancer survivor … Continued
Global Collaborative Research Push Resonates Across Airwaves The launch of the Global Ovarian Cancer Research Consortium has garnered significant media attention, with coverage appearing on NBC News Radio, FOX 5 Washington D.C., KUNS-TV Seattle, WRC-TV Washington D.C. (NBC), WJFF-FM New York (NPR affiliate), and FemTech Insider, among others. The Consortium’s inaugural initiative is a new AI Accelerator Grant — a … Continued
Ovarian Cancer Research Alliance (OCRA) has announced that registration for its International Gynecologic Cancer Conference, taking place online from September 15–17, 2025, will be free for all attendees. This annual online event is designed for anyone impacted by gynecologic cancers — patients, survivors, caregivers, and advocates. You’ll hear from leading researchers and clinicians, connect with others who understand … Continued
Ovarian Cancer Research Alliance’s Vice President of Policy, Chad Ramsey, spoke with Ellen Bryan of WUSA-TV’s Great Day Washington, and shared important new findings from a paper co-authored by OCRA and Komodo Health. The analysis reveals that nearly half of women diagnosed with ovarian cancer don’t receive essential genetic testing, despite its impact on treatment and … Continued
Join us Wednesday, April 9, 2025, for a FREE online seminar to learn about the importance of genetics and biomarkers on the treatment of endometrial cancer. This comprehensive program will cover essential topics including the difference between genetics and biomarkers, what tests are most effective in understanding treatment options, which testing is needed at diagnosis vs. recurrence, … Continued
A Year of Progress: Advances in the Fight Against Ovarian and All Gynecologic Cancers This year, your support enabled Ovarian Cancer Research Alliance (OCRA) to make incredible strides in research, advocacy, and patient support for those facing ovarian and all gynecologic cancers. With your help, we expanded our support programs, fostered critical collaborations, and continued … Continued
Get email updates about research news, action alerts, and ways to join the fight.
